Jason R. Westin - Researcher Profile

Publications

2 shown

Tisagenlecleucel in Adult Relapsed or Refractory Diffuse Large B-Cell Lymphoma

Stephen J. Schuster , Michael Bishop , Constantine S. Tam +21 more

In this international study of CAR T-cell therapy in relapsed or refractory diffuse large B-cell lymphoma in adults, high rates of durable responses were produced with the use o...

2018 New England Journal of Medicine 3775 citations

Axicabtagene Ciloleucel as Second-Line Therapy for Large B-Cell Lymphoma

Frederick L. Locke , David B. Miklos , Caron A. Jacobson +28 more

Axi-cel therapy led to significant improvements, as compared with standard care, in event-free survival and response, with the expected level of high-grade toxic effects. (Funde...

2021 New England Journal of Medicine 1322 citations

Frequent Co-Authors

Researcher Info

h-index: 2
Publications: 2
Citations: 5,097
Institution: The University of Texas MD Anderson Cancer Center

External Links

ORCID Profile Google Scholar

Identifiers

ORCID: 0000-0002-1824-2337

Impact Metrics

h-index 2

h-index: Number of publications with at least h citations each.